Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
2020 · Cancer Discovery · 191 citations
https://doi.org/10.1158/2159-8290.cd-20-0775
D
Diana Restifo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
97
Papers
716
Citations
8
h-index
8
i10-index
Diana Restifo is an academic researcher. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer, Lipids, and Metabolism & Inflammatory mediators and NSAID effects. The author has an h-index of 8, co-authored 83 publications.
ORCID: 0000-0002-8271-2831Papers by this author
worksEndogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR
2015 · Cell Reports · 82 citations
https://doi.org/10.1016/j.celrep.2015.08.023
Targeting C4-Demethylating Genes in the Cholesterol Pathway Sensitizes Cancer Cells to EGF Receptor Inhibitors via Increased EGF Receptor Degradation
2012 · Cancer Discovery · 74 citations
https://doi.org/10.1158/2159-8290.cd-12-0031
Data from Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies
2024 · 0 citations
https://doi.org/10.1158/1535-7163.c.6861327.v2
Supplementary figures and tables legends from Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies
2024 · 0 citations
https://doi.org/10.1158/1535-7163.27036548
Supplementary Figure 2 from Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies
2024 · 0 citations
https://doi.org/10.1158/1535-7163.27036557
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat